MTVA Doses First Patient in 48‑64 mg DA‑1726 Phase 1 Obesity Study, 40‑Subject Trial, Dual GLP‑1/GCGR Agonist
MetaVia Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $2.73
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS